SXT Pharmaceuticals(US:SXTC) Jin Rong Jie·2025-08-13 14:39Core Insights - Su Xuan Tang (SXTC) experienced a 3.11% increase in stock price, reaching $1.609 per share, with a total market capitalization of $18.7 million as of August 13 [1] - Financial data indicates that as of March 31, 2025, Su Xuan Tang's total revenue was $1.7409 million, reflecting a year-on-year decrease of 9.73%, while the net profit attributable to shareholders was -$3.3037 million, a decline of 6.62% year-on-year [1] Company Overview - Su Xuan Tang Pharmaceutical Co., Ltd. is an innovative Chinese pharmaceutical company focused on the research, development, production, and sales of traditional Chinese medicine (TCM) decoction pieces, particularly modern TCM decoction pieces for direct oral consumption and infusion [1] - TCM decoction pieces have been widely used in China for thousands of years, representing a significant aspect of traditional Chinese medicine [1]